Goldman Sachs
HOLX

Goldman Sachs’s Hologic HOLX Stock Holding History

Goldman Sachs’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,322,673
Closed -$176M – 6769
2026
Q1 		$176M Buy
2,322,673
+1,316,484
+131% +$99M 0.02% 731
2025
Q4 		$75M Sell
1,006,189
-318,474
-24% -$23.3M 0.01% 1191
2025
Q3 		$89.4M Buy
1,324,663
+593,472
+81% +$39.4M 0.01% 1020
2025
Q2 		$47.6M Sell
731,191
-329,422
-31% -$19.7M 0.01% 1370
2025
Q1 		$65.5M Sell
1,060,613
-135,148
-11% -$8.95M 0.01% 1045
2024
Q4 		$86.2M Sell
1,195,761
-305,683
-20% -$23.9M 0.01% 893
2024
Q3 		$122M Buy
1,501,444
+211,506
+16% +$16.9M 0.02% 711
2024
Q2 		$95.8M Sell
1,289,938
-426,530
-25% -$32M 0.02% 822
2024
Q1 		$134M Buy
1,716,468
+402,190
+31% +$29.9M 0.02% 634
2023
Q4 		$93.9M Buy
1,314,278
+71,222
+6% +$4.96M 0.02% 817
2023
Q3 		$86.3M Buy
1,243,056
+179,723
+17% +$13.6M 0.02% 797
2023
Q2 		$86.1M Sell
1,063,333
-355,030
-25% -$29M 0.02% 783
2023
Q1 		$114M Buy
1,418,363
+358,008
+34% +$28.8M 0.03% 630
2022
Q4 		$79.3M Buy
1,060,355
+32,293
+3% +$2.3M 0.02% 850
2022
Q3 		$66.3M Sell
1,028,062
-246,823
-19% -$17.1M 0.02% 921
2022
Q2 		$88.3M Buy
1,274,885
+611,486
+92% +$45.4M 0.02% 755
2022
Q1 		$51M Sell
663,399
-460,150
-41% -$33.1M 0.01% 1260
2021
Q4 		$86M Sell
1,123,549
-437,277
-28% -$32.1M 0.02% 902
2021
Q3 		$115M Sell
1,560,826
-1,303,707
-46% -$97.8M 0.02% 671
2021
Q2 		$191M Sell
2,864,533
-535,716
-16% -$35.8M 0.04% 430
2021
Q1 		$253M Sell
3,400,249
-2,283
-0.1% -$173K 0.06% 300
2020
Q4 		$248M Buy
3,402,532
+353,999
+12% +$25M 0.06% 273
2020
Q3 		$203M Buy
3,048,533
+2,364,905
+346% +$150M 0.06% 327
2020
Q2 		$39M Sell
683,628
-733,005
-52% -$36M 0.01% 1166
2020
Q1 		$49.7M Sell
1,416,633
-453,726
-24% -$21.6M 0.02% 859
2019
Q4 		$97.7M Buy
1,870,359
+189,485
+11% +$9.43M 0.02% 710
2019
Q3 		$84.9M Buy
1,680,874
+287,827
+21% +$14.2M 0.02% 756
2019
Q2 		$66.9M Buy
1,393,047
+401,345
+40% +$18.6M 0.02% 956
2019
Q1 		$48M Sell
991,702
-79,224
-7% -$3.57M 0.01% 1155
2018
Q4 		$44M Buy
1,070,926
+288,534
+37% +$11.8M 0.01% 1193
2018
Q3 		$32.1M Sell
782,392
-233,565
-23% -$9.44M 0.01% 1559
2018
Q2 		$40.4M Sell
1,015,957
-165,415
-14% -$6.36M 0.01% 1368
2018
Q1 		$44.1M Sell
1,181,372
-213,128
-15% -$8.61M 0.01% 1283
2017
Q4 		$59.6M Sell
1,394,500
-115,628
-8% -$4.61M 0.01% 1158
2017
Q3 		$55.4M Buy
1,510,128
+34,450
+2% +$1.39M 0.01% 1210
2017
Q2 		$67M Sell
1,475,678
-1,224,822
-45% -$54.1M 0.02% 1055
2017
Q1 		$115M Sell
2,700,500
-39,953
-1% -$1.63M 0.03% 679
2016
Q4 		$110M Buy
2,740,453
+17,876
+0.7% +$690K 0.03% 714
2016
Q3 		$106M Buy
2,722,577
+482,499
+22% +$18.2M 0.03% 680
2016
Q2 		$77.5M Sell
2,240,078
-1,074,434
-32% -$37.2M 0.03% 821
2016
Q1 		$114M Buy
3,314,512
+310,698
+10% +$10.8M 0.04% 593
2015
Q4 		$116M Buy
3,003,814
+1,518,808
+102% +$59.1M 0.04% 586
2015
Q3 		$58.1M Buy
1,485,006
+1,157,557
+354% +$45.9M 0.02% 935
2015
Q2 		$12.5M Sell
327,449
-309,513
-49% -$10.8M ﹤0.01% 2161
2015
Q1 		$21M Buy
636,962
+88,683
+16% +$2.72M 0.01% 1714
2014
Q4 		$14.7M Sell
548,279
-45,600
-8% -$1.18M ﹤0.01% 2051
2014
Q3 		$14.4M Buy
593,879
+177,894
+43% +$4.49M ﹤0.01% 2052
2014
Q2 		$10.5M Sell
415,985
-35,681
-8% -$834K ﹤0.01% 2320
2014
Q1 		$9.71M Sell
451,666
-104,517
-19% -$2.25M ﹤0.01% 2392
2013
Q4 		$12.4M Sell
556,183
-228,556
-29% -$5.04M ﹤0.01% 2170
2013
Q3 		$16.2M Sell
784,739
-8,626,489
-92% -$184M 0.01% 1798
2013
Q2 		$182M Buy
+9,411,228
New +$197M 0.07% 313

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's HOLX Position: Q2 2026 in Review

Goldman Sachs sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,322,673 shares — an estimated $176M sold.

Goldman Sachs first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $253M in Q1 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Goldman Sachs reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,322,673 Hologic shares in Q2 2026, an estimated $176M.
  • Goldman Sachs first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Goldman Sachs's Hologic position peaked at $253M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.